Kronos Bio, Inc. Common Stock
KRON
XNAS
•
PHARMACEUTICAL PREPARATIONS
Market Cap
54M
Short interest (May 30)
1.2%
Net Short (Jun 18 ): -0.2%
Borrow Fee
1.19%
Available Shares
0
Price Chart
Company Overview
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.
Company Info
Exchange:
NASDAQ
Industry:
PHARMACEUTICAL PREPARATIONS
CIK:
0001741830
Asset Type:
CS
Market Data
Market Cap:
$53,957,754
Employees:
8
Status:
Active
Short Interest
Current Borrow Fee
1.19%
Range: 1.19% -
1.19%
Available Shares
0
Range: 0 -
0
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.